.

Make Better Decisions

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

McKesson
QuintilesIMS
Healthtrust
Accenture
Johnson and Johnson
Boehringer Ingelheim
Cipla
Express Scripts
Chubb
Chinese Patent Office

Generated: November 18, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 017823

« Back to Dashboard
NDA 017823 describes HALOG, which is a drug marketed by Westwood Squibb, Sun Pharm Inds Inc, Bristol Myers Squibb, and Ranbaxy, and is included in six NDAs. It is available from three suppliers. Additional details are available on the HALOG profile page.

The generic ingredient in HALOG is halcinonide. There are seven drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the halcinonide profile page.

Summary for 017823

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:0
Therapeutic Class:Hormonal Agents, Stimulant/Replacement/Modifying (Adrenal)

Pharmacology for NDA: 017823

Medical Subject Heading (MeSH) Categories for 017823

Suppliers and Packaging for NDA: 017823

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
HALOG
halcinonide
SOLUTION;TOPICAL 017823 NDA E.R. Squibb & Sons, L.L.C. 0003-0249 0003-0249-15 20 mL in 1 BOTTLE, PLASTIC (0003-0249-15)
HALOG
halcinonide
SOLUTION;TOPICAL 017823 NDA E.R. Squibb & Sons, L.L.C. 0003-0249 0003-0249-20 60 mL in 1 BOTTLE, PLASTIC (0003-0249-20)

Summary for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:SOLUTION;TOPICALStrength0.1%
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Citi
Dow
Chubb
Argus Health
Harvard Business School
Novartis
Cerilliant
McKinsey
Cipla

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot